Clinical Trial: A randomized, double-blind, three-arm, placebo/active-controlled, multicenter clinical trial to evaluate the efficacy and safety of Ferrous Maltol Capsules in patients with inflammatory bowel disease complicated by iron deficiency anemia (China)

China, Aug. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized, double-blind, three-arm, placebo/active-controlled, multicenter clinical trial to evaluate the efficacy and safety of Ferrous Maltol Capsules in patients with inflammatory bowel disease complicated by iron deficiency anemia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130008

Registration Time: 2026/08/12

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital, Sun Yat-sen University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337246

Published by HT Digital Content Services with permission from Health Daily Digest...